Adalimumab-Induced Thrombocytopenia in a Patient With Hidradenitis Suppurativa

被引：5
|
作者：
Al-Tkrit, Amna [1 ]
Obada, Zaid [1 ]
Muqeet, Sara [1 ]
Cervantes, Jose [2 ]
机构：
[1] Jama Hosp Med Ctr, Internal Med, Queens, NY 11418 USA
[2] Jama Hosp Med Ctr, Hematol & Med Oncol, Queens, NY USA
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2021年 / 13卷 / 04期
关键词：
adalimumab; anti-tumor necrosis factor-alpha (anti-tnf-alpha); thrombocytopenia; platelet count; hematological abnormalities; drug-induced thrombocytopenia (dit); hidradenitis suppurativa; intravenous immunoglobulin (ivig);
D O I：
10.7759/cureus.14769
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Adalimumab-induced thrombocytopenia is a rarely occurring condition that may present with hemorrhagic manifestations. This report describes a case of a patient who presented with severe, symptomatic thrombocytopenia while on adalimumab for the treatment of hidradenitis suppurativa. The patient responded to treatment with steroids, intravenous immunoglobulin (IVIG), and platelet transfusion, in addition to discontinuation of adalimumab.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Efficacy of adalimumab in recalcitrant hidradenitis suppurativa
    Sotiriou, Elena
    Apalla, Zoe
    Vakirlis, Eustratios
    Ioannides, Demetrios
    EUROPEAN JOURNAL OF DERMATOLOGY, 2009, 19 (02) : 180 - 181
  • [32] Recalcitraxt hidradenitis suppurativa treated with adalimumab
    Ravat, F
    O'Reilly, D
    Handfield-Jones, S
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P58 - P58
  • [33] Adalimumab dose deintensification in hidradenitis suppurativa
    Cembrero Saralegui, Hirune
    Alfageme Roldan, Fernando
    Turrion Merino, Lucia
    Cabeza Martinez, Rita
    Elosua Gonzalez, Marta
    Roustan Gullon, Gaston
    EXPERIMENTAL DERMATOLOGY, 2020, 29 : 44 - 44
  • [34] Paling in the face of treatment of hidradenitis suppurativa: A case report of new onset vitiligo in a patient with hidradenitis suppurativa treated with adalimumab
    Charlton, Olivia
    Smith, Saxon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB249 - AB249
  • [35] Adalimumab-induced paradoxical psoriasis treated with biologics targeting the IL-17/IL-23 axis in patients with hidradenitis suppurativa
    Tsiogka, Aikaterini
    Liakou, Aikaterini I.
    Agiasofitou, Efthimia
    Gregoriou, Stamatis
    Stratigos, Alexander
    Rigopoulos, Dimitrios
    Kontochristopoulos, Georgios
    DERMATOLOGY, 2023, 239 (06) : 937 - 941
  • [36] Adalimumab-induced porokeratosis
    Frew, John W.
    Parsi, Kurosh
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2015, 56 (03) : E80 - E81
  • [37] Adalimumab-induced urticaria
    Mallo, S.
    Santos-Juanes, J.
    ACTAS DERMO-SIFILIOGRAFICAS, 2007, 98 (07): : 511 - 512
  • [38] Adalimumab-induced aseptic meningitis in a patient with rheumatoid arthritis
    Berti, Pier
    Schwarz, Andreas
    Pirillo, Vania
    Lanzinger, Siglinde
    Kluge, Reinhard
    Cagini, Angelo
    Karner, Martin
    Zampogna, Giuseppe
    Dejaco, Christian
    JOINT BONE SPINE, 2022, 89 (04)
  • [39] Adalimumab-induced psoriasis in a patient with Crohn’s disease
    Ugur Korkmaz
    Ali Erkan Duman
    Gokhan Dindar
    Hasan Yilmaz
    Ibrahim Hakki Dursun
    Altay Celebi
    Omer Senturk
    Sadettin Hulagu
    Indian Journal of Gastroenterology, 2013, 32 (2) : 135 - 136
  • [40] Adalimumab-induced sarcoidosis
    Trossello, B.
    Robert, J. P.
    Polla, L.
    Gabay, C.
    Mazza-Stalder, J.
    SWISS MEDICAL WEEKLY, 2018, 148 : 14S - 15S
12345